We are live on ! Find out more
OXFD

Oxford Immunotec Global PLC Ordinary Shares
OXFD

Delisted

OXFD was delisted on the 5th of March, 2021.

Back to rankings

73 hedge funds and large institutions have $274M invested in Oxford Immunotec Global PLC Ordinary Shares in 2016 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 30 increasing their positions, 23 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,100% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 1

67% more funds holding in top 10

Funds holding in top 10: 3 → 5 (+2)

30% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 23

23% more capital invested

Capital invested by funds: $223M → $274M (+$51.2M)

18% more funds holding

Funds holding: 62 → 73 (+11)

Holders
73
Holders Change
+11
Holders Change %
+17.74%
% of All Funds
1.82%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.13%
New
12
Increased
30
Reduced
23
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RI
RTW Investments
New York
+$4.31M
2
RG
Redmile Group
California
+$3.79M
3
PC
Polar Capital
United Kingdom
+$3.36M
4
BFA
BlackRock Fund Advisors
California
+$1.31M
5
DM
Deerfield Management
New York
+$908K

Top Sellers

Rank Fund Capital Flow
1
CV
Clarus Ventures
Massachusetts
-$13.9M
2
ECM
Endurant Capital Management
California
-$1.34M
3
CWG
C WorldWide Group
Denmark
-$562K
4
WRF
Waddell & Reed Financial
Kansas
-$394K
5
GPGA
Grandeur Peak Global Advisors
Utah
-$339K
Name Holding Trade Value Shares
Change 		Change in
Stake
EIM
26
Essex Investment Management
Massachusetts
$1.35M +$469K +33,394 +59%
NA
27
Neuburgh Advisers
California
$1.33M +$1.25M +89,250 New
KCM
28
Kornitzer Capital Management
Kansas
$1.14M -$295K -21,000 -22%
FCM
29
Flinton Capital Management
Pennsylvania
$1.1M +$1.03M +73,500 New
TCIM
30
TIAA CREF Investment Management
New York
$1.08M +$84.5K +6,016 +9%
Bank of New York Mellon
31
Bank of New York Mellon
New York
$1.05M +$15.7K +1,117 +2%
NIP
32
Nicholas Investment Partners
California
$1.02M -$98.6K -7,025 -9%
BC
33
Birchview Capital
Vermont
$1.01M – – –
Morgan Stanley
34
Morgan Stanley
New York
$966K +$850K +60,551 +1,493%
Vanguard Group
35
Vanguard Group
Pennsylvania
$961K +$57.3K +4,081 +7%
SIM
36
Spark Investment Management
New York
$914K +$307K +21,900 +56%
TAM
37
Tyers Asset Management
Texas
$863K +$811K +57,750 New
Neuberger Berman Group
38
Neuberger Berman Group
New York
$824K -$25.1K -1,791 -3%
KeyBank National Association
39
KeyBank National Association
Ohio
$687K – – –
California State Teachers Retirement System (CalSTRS)
40
California State Teachers Retirement System (CalSTRS)
California
$682K -$19.7K -1,400 -3%
Geode Capital Management
41
Geode Capital Management
Massachusetts
$646K +$66.8K +4,762 +12%
JP Morgan Chase
42
JP Morgan Chase
New York
$641K +$602K +42,850 New
GHCM
43
Glen Harbor Capital Management
California
$628K +$590K +42,000 New
Charles Schwab
44
Charles Schwab
California
$606K +$156K +11,100 +38%
TA
45
Teachers Advisors
New York
$597K +$91.9K +6,550 +20%
Susquehanna International Group
46
Susquehanna International Group
Pennsylvania
$543K +$510K +36,308 New
D.E. Shaw & Co
47
D.E. Shaw & Co
New York
$538K +$117K +8,313 +30%
Citigroup
48
Citigroup
New York
$500K +$444K +31,641 +1,737%
AAP
49
Ardsley Advisory Partners
Connecticut
$449K -$140K -10,000 -25%
Wells Fargo
50
Wells Fargo
California
$430K +$106K +7,579 +36%
1
2
3

OXFD Hedge Fund Activity: Q4 2016 in Review

73 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Oxford Immunotec Global PLC Ordinary Shares (OXFD) for Q4 2016, worth a combined $274M — up 23% from $223M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new OXFD positions and 1 closed out — a net gain of 11 holders — while 30 added to existing stakes and 23 trimmed.

The largest buyer was RTW Investments, adding an estimated $4.31M. The largest seller was Clarus Ventures, cutting an estimated $13.9M.

  • 73 institutional investors held Oxford Immunotec Global PLC Ordinary Shares (OXFD) as of Q4 2016, up from 62 in Q3 2016.
  • Funds reported $274M of Oxford Immunotec Global PLC Ordinary Shares stock for Q4 2016, up 23% quarter-over-quarter.
  • 12 funds opened new Oxford Immunotec Global PLC Ordinary Shares positions in Q4 2016 and 1 closed out, a net change of +11 holders.
  • The largest Oxford Immunotec Global PLC Ordinary Shares buyer in Q4 2016 was RTW Investments, an estimated $4.31M added.
  • The largest Oxford Immunotec Global PLC Ordinary Shares seller in Q4 2016 was Clarus Ventures, an estimated $13.9M sold.

Based on aggregated 13F filings for Q4 2016.